LGNYZ
LIGAND PHARMS GENERAL CVRstockOTCRight
EODNov 19, 2026
0.046USD+4.545%(+0.002)10,000
LGNYZ Financials
In Q3 FY 2026 (ended ), LIGAND PHARMS GENERAL CVR (LGNYZ) reported revenue of $78.75M, net income of −$28.49M, operating cash flow of −$27.59M, and assets of $2.24B (filed ).
Loading financial statements…